The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
09 Oct 2024
09 Oct 2024
Historique:
received:
28
04
2023
accepted:
14
08
2024
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
9
10
2024
Statut:
aheadofprint
Résumé
Advanced urothelial cancer is a frequently lethal disease characterized by marked genetic heterogeneity
Identifiants
pubmed: 39385020
doi: 10.1038/s41586-024-07955-3
pii: 10.1038/s41586-024-07955-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Faltas, B. M. et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat. Genet. 48, 1490–1499 (2016).
pubmed: 27749842
pmcid: 5549141
doi: 10.1038/ng.3692
Hadi, K. et al. Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs. Cell 183, 197–210.e32 (2020).
pubmed: 33007263
pmcid: 7912537
doi: 10.1016/j.cell.2020.08.006
Swanton, C., McGranahan, N., Starrett, G. J. & Harris, R. S. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5, 704–712 (2015).
pubmed: 26091828
pmcid: 4497973
doi: 10.1158/2159-8290.CD-15-0344
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018
pmcid: 7054213
doi: 10.1038/s41586-020-1943-3
Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970–976 (2013).
pubmed: 23852170
pmcid: 3789062
doi: 10.1038/ng.2702
Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
pubmed: 22608084
pmcid: 3414841
doi: 10.1016/j.cell.2012.04.024
Liu, W. et al. The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer. Cancer Res. 83, 506–520 (2023).
pubmed: 36480186
doi: 10.1158/0008-5472.CAN-22-2912
Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732–1740 (2019).
pubmed: 31740835
pmcid: 6887544
doi: 10.1038/s41588-019-0525-5
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836.e16 (2019).
pubmed: 30982602
pmcid: 6506336
doi: 10.1016/j.cell.2019.03.001
Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75–82 (2020).
pubmed: 33004514
doi: 10.1126/science.aba8347
Li, R. et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science 370, 82–89 (2020).
pubmed: 33004515
doi: 10.1126/science.aba7300
Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122–128 (2020).
pubmed: 32025013
pmcid: 7054212
doi: 10.1038/s41586-019-1907-7
Gorelick, A. N. et al. Phase and context shape the function of composite oncogenic mutations. Nature 582, 100–103 (2020).
pubmed: 32461694
pmcid: 7294994
doi: 10.1038/s41586-020-2315-8
Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540–556.e25 (2017).
pubmed: 28988769
pmcid: 5687509
doi: 10.1016/j.cell.2017.09.007
Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112–121 (2020).
pubmed: 32025012
pmcid: 7025897
doi: 10.1038/s41586-019-1913-9
Pecorino, L. T., Verhaak, R. G. W., Henssen, A. & Mischel, P. S. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance. Biochem. Soc. Trans. 50, 1911–1920 (2022).
pubmed: 36355400
pmcid: 9788557
doi: 10.1042/BST20221045
Deshpande, V. et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat. Commun. 10, 392 (2019).
pubmed: 30674876
pmcid: 6344493
doi: 10.1038/s41467-018-08200-y
van Leen, E., Brückner, L. & Henssen, A. G. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy. Nat. Genet. 54, 107–114 (2022).
pubmed: 35145302
doi: 10.1038/s41588-021-01000-z
Bao, L., Zhong, X., Yang, Y. & Yang, L. Starfish infers signatures of complex genomic rearrangements across human cancers. Nat. Cancer 3, 1247–1259 (2022).
pubmed: 35835961
pmcid: 11077613
doi: 10.1038/s43018-022-00404-y
Bergstrom, E. N. et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. Nature 602, 510–517 (2022).
pubmed: 35140399
pmcid: 8850194
doi: 10.1038/s41586-022-04398-6
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82–93 (2020).
doi: 10.1038/s41586-020-1969-6
Kim, H. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat. Genet. 52, 891–897 (2020).
pubmed: 32807987
pmcid: 7484012
doi: 10.1038/s41588-020-0678-2
Bertoli, C., Skotheim, J. M. & de Bruin, R. A. M. Control of cell cycle transcription during G1 and S phases. Nat. Rev. Mol. Cell Biol. 14, 518–528 (2013).
pubmed: 23877564
pmcid: 4569015
doi: 10.1038/nrm3629
Lange, J. T. et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat. Genet. 54, 1527–1533 (2022).
pubmed: 36123406
pmcid: 9534767
doi: 10.1038/s41588-022-01177-x
Dharanipragada, P. et al. Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma. Cancer Discov. 13, 880–909 (2023).
pubmed: 36700848
pmcid: 10068459
doi: 10.1158/2159-8290.CD-22-0787
Zhu, Y. et al. Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription. Cancer Cell 39, 694–707.e7 (2021).
pubmed: 33836152
pmcid: 8119378
doi: 10.1016/j.ccell.2021.03.006
Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184, 2239–2254.e39 (2021).
pubmed: 33831375
pmcid: 8054914
doi: 10.1016/j.cell.2021.03.009
Thomsen, M. B. H. et al. Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer. Sci. Rep. 7, 11702 (2017).
pubmed: 28916750
pmcid: 5600970
doi: 10.1038/s41598-017-11291-0
Jamal-Hanjani, M. et al. Tracking the evolution of non–small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112
doi: 10.1056/NEJMoa1616288
Natesan, D. et al. APOBEC mutational signature and tumor mutational burden as predictors of clinical outcomes and treatment response in patients with advanced urothelial cancer. Front. Oncol. 12, 816706 (2022).
pubmed: 35321431
pmcid: 8935010
doi: 10.3389/fonc.2022.816706
Green, A. M. et al. APOBEC3A damages the cellular genome during DNA replication. Cell Cycle 15, 998–1008 (2016).
pubmed: 26918916
pmcid: 4889253
doi: 10.1080/15384101.2016.1152426
Petljak, M. et al. Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis. Cell 176, 1282–1294.e20 (2019).
pubmed: 30849372
pmcid: 6424819
doi: 10.1016/j.cell.2019.02.012
Jones, R. T. et al. NPEPPS is a druggable driver of platinum resistance. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-23-1976 (2024).
Chang, Y.-W. et al. Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects. Oncotarget 5, 3823–3835 (2014).
pubmed: 25003617
pmcid: 4116523
doi: 10.18632/oncotarget.1709
Hua, Y. et al. Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma. Cancer 118, 5140–5154 (2012).
pubmed: 22415601
doi: 10.1002/cncr.27496
Bauvois, B. et al. Activation of interferon signaling in chronic lymphocytic leukemia cells contributes to apoptosis resistance via a JAK-Src/STAT3/Mcl-1 signaling pathway. Biomedicines 9, 188 (2021).
pubmed: 33668421
pmcid: 7918075
doi: 10.3390/biomedicines9020188
Lin, W. et al. Discovery and validation of nitroxoline as a novel STAT3 inhibitor in drug-resistant urothelial bladder cancer. Int. J. Biol. Sci. 17, 3255–3267 (2021).
pubmed: 34421363
pmcid: 8375225
doi: 10.7150/ijbs.63125
Juliachs, M. et al. The PDGFRβ–AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin. Cancer Res. 20, 658–667 (2014).
pubmed: 24277456
doi: 10.1158/1078-0432.CCR-13-1131
Ji, Y. et al. Anlotinib exerts inhibitory effects against cisplatin-resistant ovarian cancer in vitro and in vivo. Molecules 27, 8873 (2022).
pubmed: 36558006
pmcid: 9785832
doi: 10.3390/molecules27248873
Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147–1151 (2016).
pubmed: 27609891
pmcid: 5534434
doi: 10.1126/science.aag0822
Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122–125 (2017).
pubmed: 28178237
pmcid: 5334176
doi: 10.1038/nature21356
Wang, T., Zhang, H., Zhou, Y. & Shi, J. Extrachromosomal circular DNA: a new potential role in cancer progression. J. Transl. Med. 19, 257 (2021).
pubmed: 34112178
pmcid: 8194206
doi: 10.1186/s12967-021-02927-x
Ilić, M., Zaalberg, I. C., Raaijmakers, J. A. & Medema, R. H. Life of double minutes: generation, maintenance, and elimination. Chromosoma 131, 107–125 (2022).
pubmed: 35487993
pmcid: 9470669
doi: 10.1007/s00412-022-00773-4
Meric-Bernstam, F. et al. Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial. J. Clin. Oncol. 42, 47–58 (2024).
pubmed: 37870536
doi: 10.1200/JCO.23.02005
Chen, Y., Qiu, Q., She, J. & Yu, J. Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target. Oncogene 42, 941–951 (2023).
pubmed: 36859558
pmcid: 10038807
doi: 10.1038/s41388-023-02640-7
Noer, J. B., Hørsdal, O. K., Xiang, X., Luo, Y. & Regenberg, B. Extrachromosomal circular DNA in cancer: history, current knowledge, and methods. Trends Genet. 38, 766–781 (2022).
pubmed: 35277298
doi: 10.1016/j.tig.2022.02.007
Shoshani, O. et al. Chromothripsis drives the evolution of gene amplification in cancer. Nature 591, 137–141 (2021).
pubmed: 33361815
doi: 10.1038/s41586-020-03064-z
Maciejowski, J. et al. APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis. Nat. Genet. 52, 884–890 (2020).
pubmed: 32719516
pmcid: 7484228
doi: 10.1038/s41588-020-0667-5
Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641–1654 (2015).
pubmed: 26687355
pmcid: 4687025
doi: 10.1016/j.cell.2015.11.054
Chen, J. P. et al. scCircle-seq unveils the diversity and complexity of extrachromosomal circular DNAs in single cells. Nat. Commun. 15, 1768 (2024).
pubmed: 38409079
pmcid: 10897160
doi: 10.1038/s41467-024-45972-y
Litchfield, K. et al. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell 184, 596–614.e14 (2021).
pubmed: 33508232
pmcid: 7933824
doi: 10.1016/j.cell.2021.01.002
Sjödahl, G., Eriksson, P., Liedberg, F. & Höglund, M. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification. J. Pathol. 242, 113–125 (2017).
pubmed: 28195647
pmcid: 5413843
doi: 10.1002/path.4886
Jirawatnotai, S., Hu, Y., Livingston, D. M. & Sicinski, P. Proteomic identification of a direct role for cyclin D1 in DNA damage repair. Cancer Res. 72, 4289–4293 (2012).
pubmed: 22915759
pmcid: 3432743
doi: 10.1158/0008-5472.CAN-11-3549
Seiler, R., Thalmann, G. N., Rotzer, D., Perren, A. & Fleischmann, A. CCND1/cyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response. Mod. Pathol. 27, 87–95 (2014).
pubmed: 23887292
doi: 10.1038/modpathol.2013.125
Arora, K. et al. Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms. Sci. Rep. 9, 19123 (2019).
pubmed: 31836783
pmcid: 6911065
doi: 10.1038/s41598-019-55636-3
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https://doi.org/10.48550/arXiv.1303.3997 (2013).
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199
pmcid: 2928508
doi: 10.1101/gr.107524.110
Benjamin, D. et al. Calling somatic SNVs and Indels with Mutect2. Preprint at bioRxiv https://doi.org/10.1101/861054 (2019).
Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591–594 (2018).
pubmed: 30013048
doi: 10.1038/s41592-018-0051-x
Narzisi, G. et al. Genome-wide somatic variant calling using localized colored de Bruijn graphs. Commun. Biol. 1, 20 (2018).
pubmed: 30271907
pmcid: 6123722
doi: 10.1038/s42003-018-0023-9
Wala, J. A. et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 28, 581–591 (2018).
pubmed: 29535149
pmcid: 5880247
doi: 10.1101/gr.221028.117
Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 32, 1220–1222 (2016).
pubmed: 26647377
doi: 10.1093/bioinformatics/btv710
Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014).
pubmed: 24970577
pmcid: 4197822
doi: 10.1186/gb-2014-15-6-r84
Emde, A.-K. et al. Detecting genomic indel variants with exact breakpoints in single- and paired-end sequencing data using SplazerS. Bioinformatics 28, 619–627 (2012).
pubmed: 22238266
doi: 10.1093/bioinformatics/bts019
Hubbard, T. The Ensembl genome database project. Nucleic Acids Res. 30, 38–41 (2002).
pubmed: 11752248
pmcid: 99161
doi: 10.1093/nar/30.1.38
Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878
doi: 10.1093/nar/gky1015
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
pubmed: 29165669
doi: 10.1093/nar/gkx1153
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen‐2. Curr. Protoc. Hum. Genet. https://doi.org/10.1002/0471142905.hg0720s76 (2013).
Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M. & Ng, P. C. SIFT missense predictions for genomes. Nat. Protoc. 11, 1–9 (2016).
pubmed: 26633127
doi: 10.1038/nprot.2015.123
Shihab, H. A. et al. Ranking non-synonymous single nucleotide polymorphisms based on disease concepts. Hum. Genomics 8, 11 (2014).
pubmed: 24980617
pmcid: 4083756
doi: 10.1186/1479-7364-8-11
Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
pmcid: 5018207
doi: 10.1038/nature19057
Sherry, S. T. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311 (2001).
pubmed: 11125122
pmcid: 29783
doi: 10.1093/nar/29.1.308
McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795
pmcid: 4893825
doi: 10.1186/s13059-016-0974-4
MacDonald, J. R., Ziman, R., Yuen, R. K. C., Feuk, L. & Scherer, S. W. The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res. 42, D986–D992 (2014).
pubmed: 24174537
doi: 10.1093/nar/gkt958
Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444–451 (2020).
pubmed: 32461652
pmcid: 7334194
doi: 10.1038/s41586-020-2287-8
Raine, K. M. et al. ascatNgs: identifying somatically acquired copy‐number alterations from whole‐genome sequencing data. Curr. Protoc. Bioinformatics 56, 15.9.1–15.9.17 (2016).
pubmed: 27930809
doi: 10.1002/cpbi.17
Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64–70 (2015).
pubmed: 25319062
doi: 10.1093/annonc/mdu479
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).
pubmed: 26899170
pmcid: 4762164
doi: 10.1186/s13059-016-0893-4
Kasar, S. et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat. Commun. 6, 8866 (2015).
pubmed: 26638776
doi: 10.1038/ncomms9866
Jupe, S. Chromatin modifying enzymes. Reactome https://doi.org/10.3180/react_172633.1 (2014).
Chi, P., Allis, C. D. & Wang, G. G. Covalent histone modifications—miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 10, 457–469 (2010).
pubmed: 20574448
pmcid: 3262678
doi: 10.1038/nrc2876
Gui, Y. et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet. 43, 875–878 (2011).
pubmed: 21822268
pmcid: 5373841
doi: 10.1038/ng.907
Shen, H. & Laird, P. W. Interplay between the cancer genome and epigenome. Cell 153, 38–55 (2013).
pubmed: 23540689
pmcid: 3648790
doi: 10.1016/j.cell.2013.03.008
Shyr, C. et al. FLAGS, frequently mutated genes in public exomes. BMC Med. Genomics 7, 64 (2014).
The FANTOM Consortium and the RIKEN PMI and CLST (DGT). A promoter-level mammalian expression atlas. Nature 507, 462–470 (2014).
doi: 10.1038/nature13182
Dalby, M., Rennie, S. & Andersson, R. Fantom5 transcribed enhancers In hg38. Zenodo https://doi.org/10.5281/zenodo.556775 (2017).
Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013).
pubmed: 24119843
doi: 10.1016/j.cell.2013.09.053
Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).
pubmed: 23586463
pmcid: 3637064
doi: 10.1186/1471-2105-14-128
Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).
pubmed: 27141961
pmcid: 4987924
doi: 10.1093/nar/gkw377
Xie, Z. et al. Gene Set Knowledge Discovery with Enrichr. Curr. Protoc. 1, e90 (2021).
pubmed: 33780170
pmcid: 8152575
doi: 10.1002/cpz1.90
Tarabichi, M. et al. A practical guide to cancer subclonal reconstruction from DNA sequencing. Nat. Methods 18, 144–155 (2021).
pubmed: 33398189
pmcid: 7867630
doi: 10.1038/s41592-020-01013-2
Popic, V. et al. Fast and scalable inference of multi-sample cancer lineages. Genome Biol. 16, 91 (2015).
pubmed: 25944252
pmcid: 4501097
doi: 10.1186/s13059-015-0647-8
Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).
pubmed: 30337457
pmcid: 6298579
doi: 10.1126/science.aau3879
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041.e21 (2017).
pubmed: 29056346
pmcid: 5720395
doi: 10.1016/j.cell.2017.09.042
Martincorena, I. et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
pubmed: 25999502
pmcid: 4471149
doi: 10.1126/science.aaa6806
Herms, A. & Jones, P. H. Somatic mutations in normal tissues: new perspectives on early carcinogenesis. Annu. Rev. Cancer Biol. 7, 189–205 (2023).
doi: 10.1146/annurev-cancerbio-061421-012447
Deshpande, A., Walradt, T., Hu, Y., Koren, A. & Imielinski, M. Robust foreground detection in somatic copy number data. Preprint at bioRxiv https://doi.org/10.1101/847681 (2019).
Imielinski, M., Guo, G. & Meyerson, M. Insertions and deletions target lineage-defining genes in human cancers. Cell 168, 460–472.e14 (2017).
pubmed: 28089356
pmcid: 5564321
doi: 10.1016/j.cell.2016.12.025
Zhou, M. et al. Patterns of structural variation define prostate cancer across disease states. JCI Insight 7, e161370 (2022).
pubmed: 35943799
pmcid: 9536266
doi: 10.1172/jci.insight.161370
Lee, B. T. et al. The UCSC Genome Browser database: 2022 update. Nucleic Acids Res. 50, D1115–D1122 (2022).
pubmed: 34718705
doi: 10.1093/nar/gkab959
Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696–705 (2018).
pubmed: 30293088
pmcid: 6450507
doi: 10.1038/s41568-018-0060-1
Bergstrom, E. N., Kundu, M., Tbeileh, N. & Alexandrov, L. B. Examining clustered somatic mutations with SigProfilerClusters. Bioinformatics 38, 3470–3473 (2022).
pubmed: 35595234
pmcid: 9237733
doi: 10.1093/bioinformatics/btac335
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
doi: 10.1093/bioinformatics/bts635
Veeneman, B. A., Shukla, S., Dhanasekaran, S. M., Chinnaiyan, A. M. & Nesvizhskii, A. I. Two-pass alignment improves novel splice junction quantification. Bioinformatics 32, 43–49 (2016).
pubmed: 26519505
doi: 10.1093/bioinformatics/btv642
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
pubmed: 24227677
doi: 10.1093/bioinformatics/btt656
Zhang, Y., Parmigiani, G. & Johnson, W. E. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom. Bioinform. 2, lqaa078 (2020).
pubmed: 33015620
pmcid: 7518324
doi: 10.1093/nargab/lqaa078
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281
pmcid: 4302049
doi: 10.1186/s13059-014-0550-8
Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291–304.e6 (2018).
pubmed: 29625048
pmcid: 5957518
doi: 10.1016/j.cell.2018.03.022
Rosenbloom, K. R. et al. ENCODE data in the UCSC Genome browser: year 5 update. Nucleic Acids Res. 41, D56–D63 (2012).
pubmed: 23193274
pmcid: 3531152
doi: 10.1093/nar/gks1172
Luebeck, J. et al. AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. Nat. Commun. 11, 4374 (2020).
pubmed: 32873787
pmcid: 7463033
doi: 10.1038/s41467-020-18099-z
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
pubmed: 29750242
pmcid: 6137996
doi: 10.1093/bioinformatics/bty191
Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).
pubmed: 33590861
pmcid: 7931819
doi: 10.1093/gigascience/giab008
Kolmogorov, M. et al. metaFlye: scalable long-read metagenome assembly using repeat graphs. Nat. Methods 17, 1103–1110 (2020).
pubmed: 33020656
pmcid: 10699202
doi: 10.1038/s41592-020-00971-x
Lufino, M. M., Edser, P. A. & Wade-Martins, R. Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Mol. Ther. 16, 1525–1538 (2008).
pubmed: 18628754
doi: 10.1038/mt.2008.156
Jin, C. et al. Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer. EMBO Mol. Med. 8, 702–711 (2016).
pubmed: 27189167
pmcid: 4931286
doi: 10.15252/emmm.201505869
Hall, M. D. et al. Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes. Cancer Res. 74, 3913–3922 (2014).
pubmed: 24812268
pmcid: 4153432
doi: 10.1158/0008-5472.CAN-14-0247
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
pubmed: 29409532
pmcid: 5802054
doi: 10.1186/s13059-017-1382-0
Virshup, I., Rybakov, S., Theis, F. J., Angerer, P. & Wolf, F. A. anndata: annotated data. Preprint at bioRxiv https://doi.org/10.1101/2021.12.16.473007 (2021).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819
pmcid: 6884693
doi: 10.1038/s41592-019-0619-0
Liberzon, A. et al. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021
pmcid: 4707969
doi: 10.1016/j.cels.2015.12.004
Fox, M. H. A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1, 71–77 (1980).
pubmed: 7023881
doi: 10.1002/cyto.990010114
Cyrta, J. et al. Whole-genome characterization of myoepithelial carcinomas of the soft tissue. Cold Spring Harb. Mol. Case Stud. 8, a006227 (2022).
pubmed: 36577525
pmcid: 9808553
doi: 10.1101/mcs.a006227
Mosquera, J. M. et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia 15, 1–10 (2013).
pubmed: 23358695
pmcid: 3556934
doi: 10.1593/neo.121550
Green, A. M. et al. Cytosine deaminase APOBEC3A sensitizes leukemia cells to inhibition of the DNA replication checkpoint. Cancer Res. 77, 4579–4588 (2017).
pubmed: 28655787
pmcid: 5581702
doi: 10.1158/0008-5472.CAN-16-3394
Shin, K.-J. et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl Acad. Sci. USA 103, 13759–13764 (2006).
pubmed: 16945906
pmcid: 1557799
doi: 10.1073/pnas.0606179103
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772
doi: 10.1038/nmeth.2019
Goglia, A. G. et al. Identification of novel radiosensitizers in a high-throughput, cell-based screen for DSB repair inhibitors. Mol. Cancer Ther. 14, 326–342 (2015).
pubmed: 25512618
doi: 10.1158/1535-7163.MCT-14-0765
Nguyen, D. D. et al. The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution. Zenodo https://doi.org/10.5281/zenodo.11121869 (2024).